Namita Thapar Will Get 293-Fold Return On Her Investment From This IPO – NDTV

Namita Thapar Will Get 293-Fold Return On Her Investment From This IPO  NDTVEmcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the 1,952-crore issue | Stock Market News  MintLive: Will HDFC bank provide a leg up a day after breather? Emcure Pharma IPO opens| Opening Bell  MoneycontrolNamita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?  The Economic TimesEmcure Pharma IPO opens today: GMP rises; should you subscribe to the issue?  CNBCTV18 Namita Thapar Will Get 293-Fold Return On Her Investment From This IPO  NDTVEmcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the 1,952-crore issue | Stock Market News  MintLive: Will HDFC bank provide a leg up a day after breather? Emcure Pharma IPO opens| Opening Bell  MoneycontrolNamita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?  The Economic TimesEmcure Pharma IPO opens today: GMP rises; should you subscribe to the issue?  CNBCTV18  Top stories – Google News